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ABSTRACT
Early interventions are a preferred method for addressing behavioral problems in high-risk
children, but often have only modest effects. Identifying sources of variation in intervention
effects can suggest means to improve efficiency. One potential source of such variation is the
genome. We conducted a genetic analysis of the Fast Track Randomized Control Trial, a tenyear-long intervention to prevent high-risk kindergarteners from developing adult externalizing
problems including substance abuse and antisocial behavior. We tested whether variants of the
glucocorticoid receptor gene NR3C1 were associated with differences in response to the Fast
Track intervention. We found that in European-American children, a variant of NR3C1 identified
by the single-nucleotide polymorphism rs10482672 was associated with increased risk for
externalizing psychopathology in control group children and decreased risk for externalizing
psychopathology in intervention group children. Variation in NR3C1 measured in this study was
not associated with differential intervention response in African-American children. We discuss
implications for efforts to prevent externalizing problems in high-risk children and for public
policy in the genomic era.
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INTRODUCTION
Intervention during childhood to promote human capital development has the potential to
prevent a cascade of negative outcomes, including poor health, criminal behavior, and
overreliance on government services in the future (Anderson et al., 2003; Dodge, 2009;
Eckenrode et al., 2010; Garner et al., 2011; Heckman et al., 2010; O’Connell, Boat, & Warner,
2009). Evidence of this has made strategies for investing in youth a policy priority in the United
States and globally (America’s Promise Alliance, 2013; Barnett & Masse, 2007; Belfield et al.,
2006; Heckman, 2006; Obama, 2013). A challenge is that interventions to promote human
capital development are complex and expensive and “average treatment effects” are often
modest. One reason for modest treatment effects is that intervention response varies across
subpopulations (Bloom & Michalopoulos, 2013; Imbens & Angrist, 1994; Kraemer et al., 2002).
Opportunities to maximize the fit between people and programs are therefore of keen interest in
efforts to bolster intervention impacts (Duncan & Vandell, 2012; Hinshaw, 2002). Research is
needed to uncover measureable characteristics of individuals that identify them as likely to
respond more or less positively to intervention.
A provocative finding from developmental psychology research into variation in
intervention response is that those children most at risk for adverse developmental outcomes are
often the ones who benefit most from resources and services. This phenomenon has been termed
“biological sensitivity to context” (Boyce & Ellis, 2005) or “differential susceptibility” (Belsky,
Bakermans-Kranenburg, & van IJzendoorn, 2007). Sensitive/susceptible children are especially
responsive to environmental stimuli both “for better AND for worse”: Under conditions of ample
environmental resources and support, these children achieve better outcomes relative to less
sensitive/susceptible peers; under conditions of scarce resources and inadequate support, these

4

children experience adverse outcomes relative to less sensitive/susceptible peers. Initial
formulations of this model focused on temperamental characteristics—personality-like traits of
young children—as markers of sensitivity/susceptibility. Current differential susceptibility
research is focused on genetic differences between individuals (Belsky, Bakermans-Kranenburg,
& van IJzendoorn, 2007; Belsky et al., 2009; Belsky & Pluess, 2009). The best evidence for
differential susceptibility—in which individuals who carry a particular genotype are both most
likely to develop problems under adverse conditions and most likely to benefit from advantaged
conditions—comes from studies that use randomized controlled trials to study how behavioral
interventions may have different consequences for individuals who carry different variants of
certain genes (Bakermans-Kranenburg & van Ijzendoorn, 2011; Brody et al., 2013; van
IJzendoorn et al., 2011). To date, this approach has been used primarily to study discrete, short
running interventions, including literacy support programs for preschoolers (Kegel, Bus, & van
IJzendoorn, 2011) and positive parenting interventions (Bakermans-Kranenburg et al., 2008). An
example of GxI research with a broader focus is the genetic analysis of the Strong African
American Families intervention, a 7-week, family-based youth risk-behavior prevention program
for rural African Americans (Brody et al., 2009). Here, we apply this now established method to
study genetic heterogeneity in the effects of a much longer-running trial, the 10-year Fast Track
intervention, which aimed to prevent high-risk kindergarteners from developing persistent
externalizing psychopathology.
Our analysis focused on the glucocorticoid receptor gene NR3C1, which encodes a
protein critical to human stress physiology. We studied Fast Track participants who provided
genetic data at age 21 and interview reports on externalizing problems at age 25. We tested
genetic moderation effects separately in European-American (N=242) and African-American
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(N=248) subsamples. We found that a common NR3C1 variant, identified by the single
nucleotide polymorphism (SNP)1 rs10482672, significantly moderated the effectiveness of the
Fast Track intervention among European-American participants. The less common ‘A’ allele2 of
this SNP identified children who were both (1) especially like to develop externalizing
psychopathology if they did not receive the Fast Track intervention; and (2) especially likely to
benefit in terms of reduced likelihood of developing externalizing psychopathology if they did
receive the Fast Track intervention (18 percent of treated ‘A’ carriers as compared to 75 percent
of control ‘A’ carriers manifested externalizing psychopathology at age 25 years; in contrast, 56
percent of treated non-carriers and 57 percent of control non-carriers manifested externalizing
psychopathology at age 25 years). Analyses examining children’s substance use and delinquent
behavior during grades 7-12 and the two years following high school indicated that gene-byintervention effects were apparent already during adolescence. We identified no genetic
moderation effects among African-American participants.
Findings have implications for intervention policy and research. First, previously
unobservable contours in children’s likelihood of responding to a treatment may be revealed
through genetic analysis of intervention trials. Fast Track was a ten-year multi-level intervention
program delivering services to high-risk children and their families through direct contact and
via school-based programming. A formal economic evaluation of Fast Track estimated the total
cost of the ten-year intervention at $58,000 per child (Foster, Jones, & Conduct Problems
Prevention Research Group (CPPRG), 2006). Targeting these resources at those children most
likely to benefit is therefore a priority. Second, genetic prediction of treatment response in the
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A single nucleotide polymorphism (SNP) is a single-letter change in the DNA sequence, e.g. from cytosine (C) to
thymine (T), that is present in 1 percent or more of a human population (rarer variants are usually referred to as
“mutations”).
2
An allele is any naturally occurring variation in DNA sequence. For example, a C/T SNP has two alleles, C and T.
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case of complex behavioral interventions such as Fast Track is far from ready for prime time.
But proof of concept now exists. Efforts are needed to develop data resources that can support
genome-wide investigations of gene-by-intervention interactions. Third, ethical, legal, and social
issues surrounding the use of genetic or other biological information to target complex
behavioral interventions should receive increasing attention. In addition, our findings further
highlight the now established principle that genetic influences on the development of behavioral
problems are modifiable. Moreover, they point out that genetically at-risk children may be
among those who benefit most from preventive interventions.
BACKGROUND
Children with early-starting conduct problems exhibit elevated risk for persistent
externalizing psychopathology in adulthood, including antisocial personality, alcohol, and
substance use disorders (Dodge & McCourt, 2010; Jaffee, Strait, & Odgers, 2012; Moffitt,
1993). In turn, externalizing psychopathology leads to poor individual outcomes and substantial
public costs. Substance abuse alone is estimated to account for over $600 billion a year in
increased costs to health, criminal justice, and government service systems (Centers for Disease
Control and Prevention, 2009; National Institute of Drug Abuse, 2012; Rehm et al., 2009). Such
costs underscore the critical need to intervene early and effectively with conduct-disordered
children.
The Fast Track intervention design was based on evidence that children with earlystarting conduct problems are at increased risk for later disorder due to a cascade of social
adjustment failures in family, school, and peer contexts (CPPRG, 1992; Dodge et al., 2008).
High-risk children typically enter school with a risk burden that crosses multiple domains. Early
deficits in emotion regulation and behavioral control are exacerbated by dysfunctional parenting
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and other stressors in the home environment (Dodge & McCourt, 2010, Moffitt, 1993). Exposure
to harsh parenting contributes to the child’s tendency to perceive benign social challenges as
threatening and to respond with “reactive aggression” (Dodge, Bates, & Pettit, 1990). For such
children, an accidental bump on the playground from a classmate may be perceived as a hostile
provocation requiring an aggressive response. Aggressive children are more likely than their
peers to experience social rejection and academic failure in elementary school. This in turn
increases the likelihood that they will affiliate with deviant peers in middle school and escalate
their involvement in delinquency, violence, and substance abuse through high school and young
adulthood (Dodge et al., 2008).
The Fast Track prevention program was implemented in the early 1990’s as a randomized
controlled trial to test the hypothesis that a comprehensive, sustained intervention with children
at risk for persistent conduct problems would have a lasting impact on the incidence of
externalizing behavior in adulthood. 891 high-risk youth were randomly assigned in kindergarten
to receive (or not) a 10-year comprehensive intervention. Previously published intent-to-treat
analyses indicate that Fast Track was successful in reducing externalizing behavior across the
elementary, high school, and young adult years (CPPRG, 1999; 2002; 2004; 2007; 2011; in
press). The goal of the current paper is to investigate whether genetic differences between Fast
Track participants affected how they responded to treatment. Our analysis focuses on the
glucocorticoid receptor gene NR3C1.
Hypothesized Role of the Glucocorticoid Receptor Gene (NR3C1) in Regulating Response
to the Fast Track Intervention
The Fast Track intervention was designed in part to help children develop capacities for
emotion regulation and self-control, specifically in the context of social stress. And there is
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evidence Fast Track was successful in this respect. For example, children who received the Fast
Track intervention showed improved capacity to accurately appraise benign social stimuli,
whereas control children were more likely to appraise these stimuli as threatening (Dodge,
Godwin, & CPPRG, 2013). We hypothesized that children who were more biologically sensitive
to stress would show the worst outcomes in the control arm of the trial and the best outcomes in
the intervention arm of the trial. To identify such children, we turned to a gene encoding a key
mediator of the social-stress response, the glucocorticoid receptor NR3C1.
The hypothalamus-pituitary-adrenal (HPA) axis is a key mediator of the body's response
to stress. In the face of a perceived threat, hormones released from the hypothalamus result in a
cascade of signaling processes with the end product being the release of the glucocorticoid
cortisol, the paramount stress hormone involved in energy storage and expenditure, digestion,
and immune function. Importantly, the HPA axis regulates itself by means of a negativefeedback loop. Cortisol signaling inhibits the release of hormones in the hypothalamus, downregulating HPA axis activity and allowing the body to return to homeostasis once the perceived
threat is resolved. This inhibitory signaling is mediated by glucocorticoid receptor proteins
encoded by the gene NRC31 (DeRijk et al., 2008; McEwen, 2012; Meaney, 2001; Sapolsky,
Romero, & Munck, 2000). Dysregulated glucocorticoid signaling disrupts HPA axis response to
and recovery from a wide range of stressors, and has been implicated in child and adult
manifestations of externalizing psychopathology (Fardet, Petersen, & Nazareth, 2012; Hawes,
Brennan, & Dadds, 2009; Lopez-Duran et al., 2009; McBurnett et al., 1991; Savitz, Lucki, &
Drevets, 2009; Stadler, Poustka, & Sterzer, 2010; van Zuiden et al., 2011). Particularly relevant
to the current study is evidence that children exhibiting low cortisol reactivity to experimental
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challenge respond less favorably than high cortisol-reactive children to an intervention designed
to reduce disruptive behavior (van de Wiel et al., 2004).
Prior research on the glucocorticoid receptor has linked variants in the gene with mental
health problems such as mood and substance abuse disorders (Ambroggi et al., 2009; Desrivieres
et al., 2011; Mill et al., 2009; van Rossum et al., 2006; van West et al., 2006; Zobel et al., 2008).
Studies also identify the glucocorticoid receptor variants as moderators of stress reactivity and of
developmental outcomes to environmental adversity (Bet et al., 2009; DeRijk et al., 2008;
Kumsta et al., 2007; Kumsta et al., 2009; Manenschijn et al., 2009; van West et al., 2010;
Velders et al., 2012). Based on this evidence, we hypothesized that glucocorticoid receptor
variants would differentiate individuals with a “for better and for worse” sensitivity to
environmental exposure (Belsky & Pluess, 2009), characterized by reduced rates of externalizing
psychopathology in response to intervention and elevated rates in the absence of intervention.
Study Overview
We tested whether variants of the glucocorticoid receptor gene affected response to
intervention in subsamples of European-American (N=242) and African-American (N=248) Fast
Track RCT participants who were followed prospectively from age 5 to 25 years. The outcome
was externalizing psychopathology at age 25 years.
Prior research has not clarified exactly which variants in the gene NR3C1 should be
studied (Vandenbergh & Schlomer, 2014). Therefore, we undertook a “gene-wide” association
study approach (Dick, 2011). This approach surveys variation throughout a gene and conducts
comprehensive testing. Results are then subjected to a statistical correction that accounts for
increased risk of false positives arising from multiple testing. We surveyed variation throughout

10

NR3C1 using haplotype tagging analysis3 (Dick, Latendresse, & Riley, 2011). Haplotype tagging
identified 10 single-nucleotide polymorphisms (SNPs), which were genotyped in the Fast Track
sample (Appendix Figure A1). We used linear probability models to test the interventionmoderating effect of each of these 10 SNPs. To correct for multiple testing, we applied an
adjusted Bonferroni correction (Nyholt, 2004). SNPs demonstrating significant gene-byintervention effects after correction for multiple testing were further examined for stratified main
effects in intervention vs. control groups and subjected to sensitivity analyses.
DATA & METHODS
The Fast Track Intervention Trial
The Fast Track intervention was a comprehensive prevention program for children at
high risk for persistent antisocial behavior delivered over a ten-year period, when participating
children were in the first through the tenth grades. Three successive cohorts of kindergarten
children were enrolled in a randomized controlled trial in 1991, 1992, and 1993 to yield a sample
of 891 children (445 in the intervention group and 446 in the control group). Figure 1 illustrates
the Fast Track design. Fast Track participants were selected from four geographic sites: Durham,
NC; Nashville, TN; rural PA; and Seattle, WA. Fifty-four elementary schools identified from
high-crime, low-SES neighborhoods were divided into demographically matched sets within
each site, and one set of schools was randomly assigned to intervention and one to control. The
nested boxes on the left side of the figure illustrate the multiple-gating screening procedure
(Lochman, 1995) applied to kindergarteners in the 54 schools (N=9,594). First, teacher ratings of
disruptive behavior using the Teacher Observation of Classroom Adaptation-Revised (TOCA-R)
Authority Acceptance score (Werthamer-Larsson, Kellam, & Wheeler, 1991) were used to
3

A haplotype is a set of DNA sequence polymorphisms that are commonly inherited together. A haplotype tagging
analysis is a means of identifying the minimum number of DNA sequence variants required to explain a given
threshold of variation in DNA sequence.
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identify children scoring in the highest 40 percent within cohort and site (n=3,274). These
children were further screened using parent-ratings on the Aggression scales of the Child
Behavior Checklist (Achenbach, 1991). Teacher and parent scores were standardized within site
and summed to yield a severity-of-risk screen score. Children were ranked on this risk score,
and selected into the study in order from highest risk to lowest until desired sample sizes were
reached within sites, cohorts, and conditions (979 children (10 percent of total) solicited; 891
participants—intervention n=445, control n=446—enrolled). The sample was 61 percent male,
47 percent European-American, 51 percent African-American, and 2 percent of other ethnicity.
Mean age was 6.58 years (SD = 0.48) at enrollment in the first grade. During the elementary
school phase (grades 1 to 5), intervention included a universal classroom-based implementation
of the Promoting Alternative Thinking Strategies (PATHS) curriculum (Kusche & Greenberg,
1994), and opportunities to participate in 2-hr. extracurricular “enrichment programs” consisting
of child social skills training, parent training/support groups, guided parent-child interaction, and
academic tutoring. Enrichment programs were held weekly during grade 1, biweekly during
grade 2, and monthly during grades 3 through 5. In addition, paraprofessional tutors provided
three additional 30-minute sessions per week in reading and peer-pairing to improve friendships
with classmates. Families were offered home visits every other week to promote positive
parenting behavior and parental problem solving skills. After grade 1, criterion-referenced
assessments adjusted the prescribed dosage to match need. During grades 5 and 6, children
received a middle school transition program and four parent-youth group intervention sessions
on topics of adolescent development; alcohol, tobacco, and drugs; and decision-making. In
grades 7 and 8, eight Youth Forums (Oyserman, 2000) addressed vocational opportunities, life
skills, and summer employment opportunities. In grades 7 through 10, individualized
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interventions addressed parent monitoring, peer affiliation, academic achievement, and social
cognition. Detailed description of Fast Track is available at www.fasttrackproject.org and in
published evaluations (CPPRG, 1999, 2000, 2002, 2004, 2007, 2011).
Primary Outcome Measure: Externalizing Psychopathology at Age 25 Years
Externalizing psychopathology was assessed using three standardized instruments
administered to participants by condition-blind interviewers. Each participant was also invited to
nominate a peer for an independent, confidential interview about the participant. 702 participants
(81 percent of those living) and 535 peers (76 percent of participants, net 62 percent of total)
provided data. Participation did not differ significantly by condition (n’s= 352 control and 350
intervention). For each problem indicator defined below, we coded the problem as present (1) if
either the participant or the informant interview responses met criteria, and not present (0)
otherwise. The outcome of Any Externalizing Psychopathology was defined as having any of the
following externalizing mental health problems: Antisocial Personality Disorder and Attention
Deficit/Hyperactivity Disorder (ADHD) were defined by DSM-IV criterion items from the Adult
Self Report (ASR) (Achenbach & Rescorla, 2003) instrument used for participant interviews and
the parallel Adult Behavior Checklist-Friend (ABCL-F) (Achenbach & Rescorla, 2003) used for
peer interviews. Alcohol Abuse Disorder was defined according to the Alcohol and Drug
Module of the NIMH Diagnostic Interview Schedule (DIS) (Robins et al., 1981) completed by
participants and nominated peers. Marijuana Abuse (defined as 27 or more days of use in the
past month) and Serious Substance Use (cocaine, crack, inhalants, heroin, LSD, PCP, ecstasy,
mushrooms, speed and other pills not prescribed by a physician in the past month) were defined
from participant responses to the Tobacco, Alcohol and Drugs Version-III, a 57-item open-ended
and forced-choice instrument based on measures from the National Longitudinal Study of
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Adolescent Health (Bureau of Labor Statistics, 2002) and from peer responses to an identical
instrument adapted for this study.
Additional Outcome Measures
Fast Track assessed delinquent behaviors and alcohol and cannabis use at follow-ups
from grade 7 through two years post high school. Delinquency was measured using the SelfReported Delinquency Scale from the Pittsburgh Youth Study (Huizinga & Elliott, 1987), which
measures involvement in property damage, theft, assault, and substance use. The score indexes
the proportion of 25 general delinquency behaviors in which the child was involved. Alcohol Use
and Cannabis Use were measured using the Tobacco, Alcohol and Drugs (grades 7 through12)
and Tobacco, Alcohol and Drugs-Revised (years 1 and 2 post-high school) assessment
instruments (Bureau of Labor Statistics, 2002). For alcohol, the instrument measured the number
of days consuming 5+ drinks and number of days drunk in the past year. These two numbers
were averaged to calculate days of problem drinking. For cannabis, the instrument measured
days of cannabis consumption in the past month. Detailed documentation of all Fast Track
measures is provided on the Fast Track website (www.fastrackproject.org/data-instruments.php).
Genotyping
We hypothesized that alleles of the glucocorticoid receptor gene NR3C1 would moderate
Fast Track treatment effects because of the central role the gene plays in stress physiology.
Human studies have not identified common NR3C1 variants that reliably associate with
individual differences in stress physiology. We therefore took a hypothesis-free approach to
analyzing variation within NR3C1, consistent with current best practice in genetic epidemiology
(Dick, Latendresse, & Riley, 2011). There are many common DNA sequence variants within the
NR3C1 gene. Clusters of these variants are in “linkage” (inherited together and therefore non-
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independent). We used a reference database (HapMaP version 3;
http://hapmap.ncbi.nlm.nih.gov/) to identify variants that “tagged” independent clusters of
variants (Dick et al., 2009). The ten single-nucleotide polymorphisms (SNPs) identified through
this tagging procedure were at least partially independent in the current samples (maximum
linkage disequilibrium4 as measured by R2 equal to 0.56 (European-American) and 0.53
(African-American); Appendix Figure A1).
Genotyping of the 10 SNPs was conducted using DNA extracted from buccal cells
collected at the phase 21 Fast Track follow-up using a cytology brush. DNA extraction was
performed by Penn State University. Samples were then shipped to the Virginia Institute for
Psychiatric and Behavioral Genetics for genotyping. Genotyping was conducted using
commercially available primer and probe sequences from TaqMan Assays-on-Demand (Applied
Biosystems, Foster City, CA). Duplicate genotyping produced concordance rates of 100 percent.
For samples passing quality control (genotyping success rate of >80 percent), call rates for the 10
NR3C1 SNPs ranged from 87 percent to 99 percent. All SNPs were in Hardy-Weinberg
equilibrium5 (minimum p-value>0.2 for European-American and African-American samples).
Analysis
The structure of the genome differs across ethnic groups (International HapMap
Consortium, 2007) and these differences can confound genetic association analyses (Cardon &
Palmer, 2003). Briefly, allele frequencies vary between populations separated in human
evolutionary history. These differences can give rise to spurious genetic associations in the case
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Linkage describes the tendency of closely-spaced segments of DNA to be inherited together. Linkage
disequilibrium (LD) is a measure of the degree to which pairs of alleles occur together at greater-than-chance
frequency. High LD indicates that two alleles were likely inherited together.
5
Hardy-Weinberg equilibrium is a measure of whether the observed distribution of genotypes (homozygotes and
heterozygotes) deviates from the expectation based on the frequency of individual alleles. Tests of Hardy-Weinberg
equilibrium are used as a quality control measure in genetic studies.
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that the outcome of interest is unequally distributed across ethnic groups within a sample. This
problem is conventionally referred to as “population stratification” in the genetics literature; an
accessible discussion of this issue can be found in Hamer & Sirota (2000). We address this issue
in our sample, which included both African American and white children, by conducting
analyses separately within ethnically homogenous groups.
Of 439 European-American participants enrolled in the Fast Track RCT, 62 percent
(n=270) provided a DNA sample that was successfully genotyped at NR3C1; 90 percent
(N=242) of this genetic sample were interviewed at age 25 (Treatment n=114; Control n=128).
Attrition analyses comparing the analytic sample of N=242 to the complete European-American
Fast Track sample of N=439 on the pre-intervention severity-of-risk score used to screen
children into the Fast Track RCT (see Figure 1 caption for details) found no statistically
significant differences between the full Fast Track sample and the analytic sample for either
treated or control children (p-values>0.835). Pre-intervention severity-of-risk score did not
differ between control and treated children within the analytic sample (p=0.237).
Of 452 African-American RCT participants, 62 percent (n=282) were genotyped; 88
percent (N=248) of this genetic sample were interviewed at age 25 (Treatment n=127; Control
n=121). This analytic sample did not differ from the full African-American sample on preintervention severity-of-risk scores for treatment or control groups (p-values>0.670). Preintervention severity-of-risk score did not differ between control and treated children within the
analytic sample (p=0.779).
Across the ten SNPs analyzed, frequencies of the less-common alleles ranged from 5
percent to 44 percent. The double-helix structure of DNA means that each individual carries two
copies of each nucleotide base in the DNA sequence. Each SNP genotype comprises a nucleotide
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from each strand. Therefore, individuals may carry 0, 1, or 2 copies of a given allele. Carriers of
0 or 2 copies are called “homozygotes.” Carriers of 1 copy are called “heterozygotes.” For
several SNPs, there were very few homozygotes for the less-common allele (the expected
proportion of homozygotes is the squared proportion of the allele frequency). We conducted
primary analyses assuming an additive model (SNPs were coded 0, 1, or 2 according to the
number of copies of the test allele). Because of the low frequencies of test-allele homozygotes
for some SNPs, we repeated analyses using a dominance model. In the dominance model, a value
of ‘1’ indicated the presence of one or two test alleles and a value of ‘0’ indicated the presence of
no test alleles.
To test whether variation in NR3C1 moderated the effects of the Fast Track intervention,
we fitted a series of 10 linear probability models (one for each SNP) predicting the outcome of
Any Externalizing Psychopathology at age 25 as a function of Fast Track treatment condition,
SNP genotype, and a product term measuring the interaction between treatment and genotype:
!"#$ %&' )*+,"&-./0/&1 23'4ℎ#!-+ℎ#.#1'
= 7 + 9:",-+;,&+ + <=,&#+'!, + >:",-+;,&+×=,&#+'!, + @A + ℰ
where X is a vector of covariates. All models included sex as a covariate. Sensitivity analyses
also included site, cohort and pre-intervention severity-of-risk as covariates.
Hypothesis tests were conducted with the δ coefficient for the product term testing
interaction between Fast Track treatment and genotype. We adjusted for multiple testing using a
modified Bonferoni correction according to the procedure described by Nyholt (2004). After
accounting for the linkage structure (non-0 correlation) among the ten SNPs, the significance
criteria approximating α=0.05 for the European-American and African-American samples were
p=0.0056 and p=0.0054, respectively. We conducted a series of post-hoc analyses on SNPs
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meeting the adjusted significance criterion, including sensitivity analyses and analyses
examining the diagnostic specificity of interaction effects. All analyses were conducted using
both additive and dominance models. We report coefficient estimates and p-values from the
additive model (effects in terms of each additional test allele carried). We report outcome
prevalences according to the dominance model (carriers vs. non-carriers of test alleles). All
analyses were conducted in SPSS 20.0.
RESULTS
Children in the intervention group of the Fast Track RCT were less likely to manifest Any
Externalizing Psychopathology at age 25 years as compared to peers randomized to the control
condition (prevalence for European-American children was 46 percent in the intervention group
and 61 percent in the control group, p=0.013; for African-American children, prevalence was 35
percent in the intervention group and 58 percent in the control group).
Among European-American children, the effect of intervention was moderated by
variation in the glucocorticoid receptor gene NR3C1; the Fast Track intervention was more
efficacious in preventing externalizing psychopathology among carriers of the rs10482672 ‘A’
allele (δ=-0.520, p= 0.00006). Among carriers of the ‘A’ allele, 18 percent of treated children as
compared to 75 percent of control children manifested any externalizing psychopathology at age
25 follow-up. In contrast, for non-carriers of the ‘A’ allele, 56 percent of treated children and 57
percent of control children manifested externalizing psychopathology at follow-up (Figure 2).
The remaining 9 SNPs did not show evidence of moderating Fast Track intervention response.
Among African-American children, there was no evidence that any of the measured SNPs
moderated Fast Track intervention effects. Full results for European-American and AfricanAmerican samples for all ten tested SNPs are reported in Appendix Tables A1 and A2.
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We conducted a series of sensitivity analyses to evaluate the robustness of the
rs10482672 finding among European-American participants. First, to test whether the gene-byintervention interaction was sensitive to the coding of SNP genotypes, we repeated the analysis
assuming a dominance model (in which the SNP was coded as 0 or 1 according to the absence or
presence of one or more ‘A’ alleles). Results were unchanged (δ=-0.548, p=0.00018). As a
further check, because there were few AA homozygotes for rs10482672 (n=5 treated, n=1
control), we excluded these individuals and repeated the analysis. Again, results were unchanged
(δ=-.499, p=0.00111). Second, we tested whether the gene-by-intervention interaction was
sensitive to whether externalizing psychopathology status was reported by participants as
compared to peer informants. Results were similar regardless of the source of outcome
information (for self-reports, δ=-0.415, p= 0.00106; for peer-reports, δ=-0.466, p= 0.00670).
Third, we repeated analyses with adjustment for site, cohort, and pre-intervention severity-of-risk
for externalizing psychopathology, which was found to moderate intervention effectiveness for
some outcomes in previous evaluations of Fast Track (e.g., CPPRG 2011). This analysis also
included a severity-of-risk by intervention product term (Keller, 2013). Results from this model
were unchanged (δ=-0.551, p< 0.00004).
Finally, we conducted a series of analyses to examine the specificity of the gene-byintervention interaction to the components of the Any Externalizing Psychopathology indicator
used in our discovery analysis. Figure 3 shows that, across components, carriers of the
rs10482672 ‘A’ allele experienced a more beneficial effect of intervention as compared to noncarriers, but this difference was statistically significant only in the cases of Alcohol Abuse (δ=0.427, p= 0.00086) and ADHD (δ=-0.191, p= 0.03399).
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We next asked whether the result we observed at the age-25 follow-up was already
apparent earlier in life. We examined summary measures of participants’ self-reported
delinquency, problem alcohol use, and problem cannabis use across an 8-year window spanning
grade 7 through two years post high school. Analyses were limited to the European-American
subsample. Parallel to results at age 25 follow-up, Fast Track intervention was associated with
lower levels of delinquency, alcohol use, and cannabis use during the adolescent period for
rs10482672 ‘A’ carriers; for non-carriers of the ‘A’ allele, the intervention had no effect (for
delinquency, δ=-0.034, p=0.00200; for alcohol, δ=-4.165, p= 0.00185; for cannabis, δ=-2.390,
p= 0.00714). Complete model results are reported in Appendix Tables A3 and A4.
Finally, we tested how the gene-by intervention interaction effect manifested over the
adolescent period. Fast Track intervention children who carried A-alleles exhibited a slower
progression of substance use behavior during adolescence as compared to A-carriers in the
control condition; children who did not carry an A allele exhibited similar patterns of change in
substance use during adolescence (i.e., gene-by-intervention-by-time effects in repeated
measures ANCOVA analysis for alcohol use, ηp2=0.012, p=0.014; for cannabis use, ηp2=0.017,
p=0.010). Gene-by-intervention effects on delinquency did not change over the 8-year period
(ηp2=0.007, p=0.178). Between-subjects ANCOVA analysis indicated statistically significant
differences in mean levels of externalizing behaviors (for delinquency, ηp2=0.042, p=0.002; for
alcohol use, ηp2=0.042, p=0.002; for cannabis use, ηp2=0.051, p=0.001). Complete model results
are reported in Appendix Table A5. Figure 4 shows average levels of each of the externalizing
measures from grade 7 through 2-years post high school in the intervention and control groups
for carriers and non-carriers of the rs10482672 ‘A’ allele.
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DISCUSSION AND POLICY IMPLICATIONS
We conducted a genetic analysis of treatment response in the Fast Track randomized
control trial, a 10-year-long intervention to prevent externalizing psychopathology. We tested
whether carrying certain alleles of the glucocorticoid receptor gene NR3C1 predisposed children
to benefit more or less from the Fast Track intervention. We found that European-American
children who carried one or two copies of the rs10482672 ‘A’ allele benefitted from Fast Track
intervention more than did their age- and sex-matched peers who did not carry a copy of this
allele. The difference in treatment effect between these two groups was large. For ‘A’ carriers,
18 percent of treated children manifested externalizing psychopathology at adult follow-up, as
compared to 75 percent of control children. In contrast, for children who did not carry an ‘A’
allele, Fast Track had no effect; 56 percent of treated children and 57 percent of control children
manifested externalizing psychopathology at follow-up. Sensitivity analyses indicated that
moderation of the Fast Track intervention effect on externalizing psychopathology at age 25
years by rs10482672 genotype was primarily due to increased effectiveness of the intervention in
preventing alcohol abuse and ADHD in rs10482672 ‘A’ allele carriers. Genetic moderation of
intervention effects was observable already during adolescence. Across assessments spanning
grade 7 through two years post high school, Fast Track intervention was associated with lower
levels of self-reported delinquency, alcohol use, and cannabis in children who carried an
rs10482672 ‘A’ allele, but not in their peers who did not carry an ‘A’ allele. None of the NR3C1
SNPs genotyped in our study showed evidence of moderating Fast Track intervention response
in African-American children.
The absence of replication of findings for rs10482672 in the African-American sample
may be an artifact of differences in the genomes of African-American and European-American
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children in the Fast Track sample. We used a tagging SNP approach to measure variation in
NR3C1. (Instead of identifying variants in the gene that were likely to cause differences in
intervention effects, we instead identified variants that provided a parsimonious summary of all
variation in NR3C1.) African-descent populations are more genetically diverse than Europeandescent populations and there is less linkage in African-descent as compared to Europeandescent genomes. These differences could have the result that our SNP set was a less
comprehensive measure of NR3C1 variation for the African-American children as compared to
the European-American children. Therefore, the possible causal variant that was measured with
rs10482672 in the European-American sample might have gone unmeasured in the AfricanAmerican sample.
We acknowledge limitations. First, our analysis was based on a small sample. Only 242
European-American and 248 African-American Fast Track participants met inclusion criteria.
Replication is needed. Nevertheless, use of a randomized controlled trial increases power and
bolsters confidence that results are not confounded by unmeasured correlations between
genotype and environment (Fletcher & Conley, 2013; McClelland & Judd, 1993). A specific
feature of the Fast Track design that may increase power is the focus of the trial on very highrisk children among whom rates of adult externalizing psychopathology absent treatment were
expected to be high. This expectation proved correct. By age 25 years, the majority of children in
the control condition manifested externalizing psychopathology. A second limitation of our data
is that we did not observe the complete sequence of the NR3C1 gene. Instead, we observed a set
of tagging SNPs identified from reference data. Further analyses in additional samples are
needed to identify the causal sequence that is the source of the signal detected at rs10482672.
Third, it is uncertain whether results generalize to non-white populations. To the extent that the
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tagging SNPs we observed captured less variation in the surrounding sequence in AfricanAmerican as compared to European-American children, it could lead to spurious null findings in
the African American sample. Moreover, we were unable to account for the likely substantial
genetic diversity within the African American sample. The lack of genome-wide data in our
study precluded the use of a comprehensive strategy to address potential confounding by racial
admixture. It is also the case that race differences could exist in base rates and/or reporting
behaviors related to the outcomes we studied (Costanzo et al., 2007). However, previous Fast
Track evaluations have found no evidence for race differences in program impacts on similar
outcome measures (CPPRG, 2007; 2011; in press). Fourth, analyses focused on a single gene,
the glucocorticoid receptor NR3C1. We expect there are dozens, if not hundreds of genes and
intergenic loci involved in regulating response to Fast Track and other complex behavioral
interventions. Ultimately, genome-wide investigations of variants moderating intervention
effects will be needed to uncover genetic signatures of intervention response that can be used to
select individuals into interventions. Our study provides proof of concept to motivate the
development of databases capable of supporting genome-wide inquiry.
Developing databases to conduct large-scale genome-wide gene-by-intervention
interaction research in the field of human capital development depends on two key ingredients.
First, randomized trials of interventions must collect genetic data from participants and obtain
consent for the use of these data in post hoc analyses. Second, investigators running randomized
trials must participate in collaborative networks to share data. Consortia are necessary because
genetic influences on the outcomes targeted by human capital interventions are complex and
magnitudes of individual genetic effects are likely to be very small (Benjamin et al., 2012;
Chabris et al., 2012). Consortia are possible, as illustrated by a recent genome-wide association
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study of educational attainment that integrated dozens of datasets to achieve a sample of
hundreds of thousands of individuals (Rietveld et al., 2013). Consortia are worth the effort as
evidenced by their track record in the biomedical science where, despite high complexity of
genetic influences on the outcomes studied, thousands of discoveries have been made
(www.genome.gov/gwasstudies) and clinical applications translating these discoveries are
beginning to emerge (Manolio, 2013).
Moving beyond implications for a general research agenda, findings from this specific
study can provide an opportunity to begin a discussion about the implications of genetic research
for the prevention of externalizing psychopathology in particular and, more generally, for
program development and policy in the genomic era. With respect to efforts to prevent
externalizing psychopathology, our findings indicate that (1) common genetic variation may
predispose some children to developing externalizing psychopathology; but that (2) this
predisposition is susceptible to preventative intervention. In other words, there is a group of
children that is both highly likely to develop externalizing psychopathology and also highly
likely to benefit from preventative intervention—and it may be possible to identify them. These
observations lend support to intervention strategies that target high-risk children (in contrast to
those that are delivered to the entire population), but they raise questions about how that
targeting should be conducted. Specifically, they raise the possibility that genetic information
could help to identify those children most likely to benefit from intervention. This is of particular
interest in the case of long running, costly interventions with high risk populations, such as Fast
Track.
With respect to program development and policy, we highlight three issues. (1) Genetic
differences between individuals may influence risk for adverse outcomes, e.g. externalizing
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psychopathology. But a genetic predisposition does not represent an immutable risk. In fact,
genetically mediated risks may be as treatable or more so than risks arising from environmental
exposures. (2) The way the genome relates to outcomes is complicated and may depend on
features of the environment that are amenable to policy intervention; in the Fast Track treatment
group, the same allele predicting increased risk among control children predicted a two-thirds
reduction in risk among treated children. Modifiable features of the environment that mitigate or
amplify genetic risks are appealing intervention targets because changes to these environments
benefit the population and provide added benefit to individuals carrying the genetic risk modified
by the environmental change. (3) Policy makers and program developers should begin grappling
with the ethical challenges that come with knowledge of how genetic differences between
individuals may affect response to publicly financed interventions. Medical science is involved
in ongoing debate over ethical means of incorporating genetic information into screening and
treatment decisions (Berg, Khoury, & Evans, 2011; Dancey et al., 2012; Evans, Skrzynia, &
Burke, 2001; Goldenberg & Sharp, 2012). Our tentative evidence that common genetic variation
may affect response to an intervention like Fast Track suggest that this same debate should be
going on in the social and behavioral sciences as well. To be clear, findings from our study in
particular and from behavioral genetics in general are not ready for “prime time.” But that may
not always be the case. If we are eventually able to predict which children will respond to an
intervention on the basis of their DNA (and this is not guaranteed), there are reasons we may not
wish to use this information to restrict access to the intervention. It would be helpful to begin a
conversation about such decisions now, in order that social policy may evolve with the
technology rather than in response to it.
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Figure 1. Fast Track Randomized Controlled Trial Design.
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Figure 2. Prevalence of Any Externalizing Psychopathology in European-American Fast
Track Intervention and Control Children by Carriage of the rs10482672 ‘A’ Allele. The
G/G group carried no copies of the A allele. The A Carrier group carried one or two copies of the
A allele.
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Figure 3. Prevalence of Alcohol Abuse, Cannabis Abuse, Hard Drug Use, Attention
Deficit/Hyperactivity Disorder, and Antisocial Personality Disorder in European-American
Fast Track Intervention and Control Children by Carriage of the rs10482672 ‘A’ Allele.
The G/G group carried no copies of the A allele. The A Carrier group carried one or two copies
of the A allele.
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Delinquent Behaviors Endorsed (%)

Figure 4. Delinquent Behavior, Problem Alcohol Use, and Cannabis Use in EuropeanAmerican Fast Track Control and Intervention Children by Carriage of the rs10482672
‘A’ Allele. The G/G group carried no copies of the A allele. The A Carrier group carried one or
two copies of the A allele. Gene-by-intervention interaction effects were statistically significant
(p<0.05) for mean levels of delinquency, alcohol use, and cannabis use and for change over time
in alcohol and cannabis use. Details are reported in Appendix Table A5.
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APPENDIX
Appendix Figure A1. Pairwise Linkage Disequilibrium (R2) Between Candidate SNPs in
NR3C1. Linkage disequilibrium plots were obtained from Haploview (Barrett et al., 2005).
Values displayed in each box indicate the pairwise correlation (R2) between markers. Shading
indicates the degree of correlation as measured by Dꞌ, following the standard Haploview color
scheme: high-confidence associations (LOD ≥ 2) are shaded from light pink to bright red based
on the absolute value of Dꞌ; low-confidence associations (LOD < 2) are shaded white (Dꞌ<1) or
blue (Dꞌ=1). Each subset of SNPs grouped within a black triangle is considered a “block” based
on proximity and inter-correlation criteria defined by Gabriel et al. (2002). LOD is the log of the
likelihood odds ratio, a measure of confidence in the value of Dꞌ.
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Appendix Table A1. Prevalence of any externalizing psychopathology by intervention group and genotype and test of gene-byintervention interaction for ten tag SNPs in NR3C1. Analyses were conducted separately for European-American (Panel A) and
African-American (Panel B) samples. P-values for difference in differences were calculated from linear probability models regressing
externalizing psychopathology status on genotype, intervention group, and a product term testing the GxI interaction. Models were
adjusted for sex. P-values are based on the test statistic for the product term. P-values are reported for the additive model and the
dominance model. Prevalences in the table reflect the dominance model. Bolded p-values are statistically significant at the alpha=0.05
level following Nyholt correction for multiple testing.
Appendix Table A1 - Panel A: European-American Sample
Prevalence of Any Externalizing Psychopathology at Age 25
p-value
(Gene x Intervention
Interaction)
rsID

Alleles
(Ref/Test)

Test Allele Carriers

Difference in
Differences

Non-Carriers

Test Allele
Frequency

Additive
Model

Dominance
Model

Control

Intervention

Difference

Control

Intervention

Difference

rs852980

G/C

0.44

8.40E-02

1.80E-02

64%

39%

-25%

55%

66%

11%

-36%

rs10482682

C/T

0.41

1.20E-01

3.41E-01

54%

45%

-10%

72%

49%

-24%

14%

rs4912910

G/A

0.35

7.28E-01

3.15E-01

66%

47%

-20%

54%

48%

-6%

-14%

rs2963149

A/T

0.34

5.17E-01

7.40E-01

61%

51%

-10%

59%

42%

-17%

7%

rs12655166

T/C

0.25

4.63E-01

3.32E-01

71%

48%

-23%

54%

44%

-11%

-13%

rs13182800

G/T

0.23

3.61E-01

3.36E-01

61%

40%

-22%

61%

51%

-10%

-12%

rs17209258

A/G

0.22

2.00E-03

1.00E-02

51%

59%

8%

66%

37%

-29%

37%

rs4128428

T/C

0.17

5.98E-01

6.53E-01

55%

36%

-19%

64%

51%

-13%

-6%

rs2918418

G/C

0.15

3.27E-01

1.82E-01

67%

68%

1%

58%

38%

-20%

22%

rs10482672

G/A

0.13

6.20E-05

1.83E-04

75%

18%

-57%

57%

56%

-1%

-56%
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Appendix Table A1 - Panel B: African-American Sample
Prevalence of Any Externalizing Psychopathology at Age 25
p-value
(Gene x Intervention
Interaction)
rsID

Alleles
(Ref/Test)

Test Allele Carriers

Difference in
Differences

Non-Carriers

Test Allele
Frequency

Additive
Model

Dominance
Model

Control

Intervention

Difference

Control

Intervention

Difference

rs852980

G/C

0.60

9.45E-01

7.55E-01

58%

33%

-25%

75%

44%

-31%

6%

rs10482682

C/T

0.12

8.07E-01

7.27E-01

64%

46%

-18%

56%

33%

-23%

5%

rs4912910

G/A

0.62

3.83E-01

7.60E-02

60%

32%

-28%

50%

53%

3%

-31%

rs2963149

A/T

0.28

9.33E-01

8.63E-01

67%

41%

-26%

50%

28%

-22%

-3%

rs12655166

T/C

0.06

3.12E-01

3.33E-01

91%

50%

-41%

55%

34%

-21%

-20%

rs13182800

G/T

0.20

7.79E-01

9.73E-01

63%

41%

-21%

55%

33%

-22%

0%

rs17209258

A/G

0.05

8.89E-01

8.89E-01

38%

20%

-18%

59%

37%

-22%

4%

rs4128428

T/C

0.08

7.32E-01

7.32E-01

68%

41%

-27%

54%

33%

-21%

-6%

rs2918418

G/C

0.17

3.64E-01

6.28E-01

68%

52%

-16%

53%

30%

-23%

7%

rs10482672

G/A

0.20

5.69E-01

5.99E-01

55%

36%

-19%

59%

34%

-25%

6%
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Appendix Table A2. Regression model results for age-25 externalizing psychopathology.
Analyses were conducted separately for European-American and African-American samples.
Unstandardized beta coefficients and coefficient standard errors were calculated from linear
probability models regressing externalizing psychopathology status on genotype, intervention
group, and a product term testing the GxI interaction. Genotype was coded additively, as the
number of test alleles (i.e., 0-1-2). Models were adjusted for sex.

Sample
European-American

SNP
rs852980
rs10482682
rs4912910
rs2963149
rs12655166
rs13182800
rs17209258
rs4128428
rs2918418
rs10482672

Main Effect of
Genotype
β
SE
-0.157
0.065
-0.121
0.068
-0.153
0.072
-0.112
0.074
-0.207
0.082
-0.209
0.089
0.041
0.093
-0.198
0.111
-0.071
0.106
-0.534
0.111

African-American

rs852980
rs10482682
rs4912910
rs2963149
rs12655166
rs13182800
rs17209258
rs4128428
rs2918418
rs10482672

-0.240
-0.191
-0.218
-0.235
-0.387
-0.230
-0.177
-0.264
-0.142
-0.181

0.067
0.127
0.067
0.078
0.164
0.095
0.232
0.163
0.097
0.090
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Main Effect of
Intervention
β
SE
-0.031
0.061
-0.100
0.062
0.062
0.066
0.006
0.063
0.130
0.073
-0.019
0.077
-0.129
0.072
-0.054
0.088
0.108
0.082
0.163
0.080

GxI Effect
β
SE
0.155
0.089
0.147
0.095
-0.033
0.095
0.065
0.101
-0.075
0.102
-0.101
0.111
0.344
0.111
-0.070
0.132
0.119
0.121
-0.520
0.127

0.115
0.045
0.006
0.136
0.308
0.070
-0.207
0.138
0.079
-0.081

-0.006
0.035
-0.083
-0.009
-0.175
-0.032
0.034
-0.061
0.102
0.064

0.071
0.104
0.064
0.072
0.137
0.077
0.179
0.123
0.079
0.080

0.094
0.142
0.095
0.102
0.173
0.113
0.241
0.177
0.112
0.113

Appendix Table A3. Mean levels of delinquency, problem alcohol use, and cannabis use by rs10482672 genotype and
intervention group and test of gene-by-intervention interaction. Children reported on their delinquent behavior, problem alcohol
use, and cannabis each year from grade 7 through two years post high school. Group means are based on average scores across all 8
waves of assessment. Delinquency is the proportion of 25 different delinquent behaviors the child endorsed engaging in in the past
year; Alcohol Use is the average of (a) the number of past-year days the child reported consuming 5 or more drinks in one sitting, and
(b) the number of past-year days the child reported being drunk. Cannabis Use is the number of days the child reported consuming
cannabis in the past month. Gene-by-intervention interaction p-values were calculated from ordinary least squares models regressing
average externalizing behavior on on genotype, intervention group, and a product term testing the GxI interaction. For additive
models, genotype was coded as the number of rs10482672 ‘A’ alleles (i.e., 0-1-2). For dominance models, genotype was coded as the
absence or presence of one or more ‘A’ alleles (i.e., 0-1). Models were adjusted for sex. Analyses were limited to the EuropeanAmerican subsample of participants. Unstandardized betas and coefficients are reported in Appendix Table A4. Effect size (d) =
Cohen’s d.

A-Carriers
p-value
(GxI Interaction)
Additive
Dominance
Model
Model

Mean

SD

Mean

SD

Delinquency

0.00159

0.00296

0.042

0.064

0.012

Alcohol Use

0.00185

0.00386

5.79

7.27

Cannabis Use

0.00714

0.00126

3.58

5.57

Control
(n=29)

Non-Carriers
Effect
Size

Intervention
(n=26)

Control
(n=85)

d

Effect Size
Difference
dA-Carriers dNon-Car

0.048

-0.23

0.87

3.34

5.07

-0.15

0.84

1.49

3.17

-0.11

0.86

Intervention
(n=82)

d

Mean

SD

Mean

SD

0.015

0.64

0.019

0.027

0.028

1.78

3.59

0.69

2.65

4.00

0.50

1.39

0.74

1.17

2.44
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Effect
Size

Appendix Table A4. Regression model results for adolescent delinquency, problem alcohol
use, and cannabis use. Children reported on their delinquent behavior, problem alcohol use, and
cannabis each year from grade 7 through two years post high school. Group means are based on
average scores across all 8 waves of assessment. Unstandardized beta coefficients and
coefficient standard errors were calculated from ordinary least squares models regressing
average externalizing behavior on on genotype, intervention group, and a product term testing
the GxI interaction. Genotype was coded additively, as the number of rs10482672 ‘A’ alleles
(i.e., 0-1-2). Models were adjusted for sex. Analyses were limited to the European-American
subsample of participants.

Delinquency
Alcohol Use
Cannabis Use

Main Effect of
Genotype
β
SE
0.019
0.007
2.772
0.851
1.528
0.567

Main Effect of
Intervention
β
SE
0.008
0.006
0.589
0.733
0.071
0.488
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GxI Effect
β
SE
-0.034
0.011
-4.165
1.321
-2.390
0.880

Appendix Table A5. Repeated measures ANCOVA results for adolescent delinquency, problem alcohol use, and cannabis use.
Children reported on their delinquent behavior, problem alcohol use, and cannabis each year from grade 7 through two years post high
school. For each outcome, the repeated measures factor (i.e., “Time”) was evaluated from four scores (average scores for grades 7+8,
9+10, 11+12, and post-HS 1+2). Genotype (rs10482672 ‘A’ carriers vs. non-carriers) and treatment group were entered as betweensubjects factors. Between-subjects effects correspond to group differences in average behavior over the 8-year span. Within-subjects
effects correspond to group differences in magnitude of behavior change over time. Analyses are limited to the European-American
sample. Models were adjusted for sex. MS = Mean Square. ηp2 = Partial Eta Squared.
*p<.05; **p<.01; ***p<.001.
Delinquency

Problem Alcohol Use

ηp

2

df

MS

F

Cannabis Use

ηp

2

df

MS

F

ηp2

2.01

0.009

df

MS

F

Genotype

1

0.002

0.27

0.001

1

102.9

1.07

0.005

1

82.5

Intervention

1

0.020

2.90

0.013

1

451.7

4.70 *

0.021

1

315.6

7.70 **

0.034

Genotype by Intervention

1

0.065

9.62 **

0.042

1

912.3

9.49 **

0.042

1

478.3

11.66 ***

0.051

218

0.007

217

41.0

Time

3

0.005

3.30 *

0.015

3

1458.7

0.140

3

329.5

18.73 ***

0.079

Genotype by Time

3

0.001

0.61

0.003

3

28.8

0.70

0.003

3

11.8

0.67

0.003

Intervention by Time

3

0.001

0.36

0.002

3

195.3

4.73 **

0.021

3

59.8

3.40 *

0.015

Genotype by Intervention
by Time

3

0.003

1.64

0.007

3

111.8

2.71 *

0.012

3

67.6

3.84 **

0.017

654

0.002

651

41.3

651

17.6

Between-Subjects Effects

Error

217

Within-Subjects Effects

Error

49

35.31 ***

